We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ergomed Plc | LSE:ERGO | London | Ordinary Share | GB00BN7ZCY67 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1,346.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
16/5/2018 22:17 | They seem very confident in the new strategy and its profitability. | sicilian_kan | |
16/5/2018 17:37 | Is this breaking out from its extended period of snooze? | mirabeau | |
18/4/2018 09:59 | Strategic Equity Capital plc above 5% | mfhmfh | |
13/4/2018 12:21 | after this week's results, Stephen Stamp and the CEO of the fast growing Pharmacovigilance division discuss the strategic focus on that exciting opportunities in Services. 20 min interview here: | edmonda | |
12/4/2018 13:40 | Sodding great loss = solid results? | jamtomorrow2 | |
11/4/2018 08:22 | solid results today. Outlook sounds positive with potential acquisitions to come: 'A contracted backlog of £88 million underpins Ergomed's ability to deliver its targets for 2018. Drug Safety and Medical Information services make up an increasing proportion of our overall revenues and owing to their greater predictability and exceptional growth we benefit from greater visibility than with clinical research services which, although capable of attractive margins are lumpy by nature and highly competitive. More generally during the coming period we expect to continue to deliver on our strategy of focusing on the growth and profitability of our services businesses, supplemented by acquisitions that expand the services offering or geographical coverage, or both.' All IMHO. | mfhmfh | |
09/3/2018 14:02 | PrimeVigilance@Prime PrimeVigilance Ltd on #Google | piedro | |
05/3/2018 07:25 | Is that Trading Update supposed to be a profit warning? | piedro | |
22/2/2018 12:00 | ORYX INTERNATIONAL GROWTH FUND >4% | mfhmfh | |
16/2/2018 15:18 | solid buys coming in today | mfhmfh | |
07/2/2018 11:41 | Octopus Investments Nominees Limited above 7% | mfhmfh | |
06/2/2018 09:16 | Slater investments above 10% | mfhmfh | |
29/1/2018 15:44 | Nice little proactive article below - gets blocked !! | piedro | |
25/1/2018 16:58 | Nice little proactive article below:- Ergomed’s drugs safety unit alone is worth as much as the whole business [...] | bermudashorts | |
25/1/2018 16:47 | Numis reiterates 300p target price today | mfhmfh | |
25/1/2018 16:43 | yes strong update this morning. | bermudashorts | |
25/1/2018 14:50 | - staircase, tighter spread | piedro | |
23/1/2018 14:38 | Unless they're some sort of transfer, would have expected a postitve move in share price with buys at that level. | bermudashorts | |
23/1/2018 13:41 | We should get an RNS 1,356,372 of 42,680,813 ord shares = 3.18% {x2 = 6.38%} | piedro | |
23/1/2018 12:03 | 2 big buys/huge volume today. | mfhmfh | |
17/1/2018 13:52 | Anybody know when to expect a trading update ? | nchanning | |
08/1/2018 15:39 | FWIW ... Equity Development Ergomed plc 2018 – creating further value | piedro | |
02/1/2018 16:49 | Timbo/anyone still here? Any thoughts on replacement of Dr Dan Weng as CEO? He didn't last very long! | bermudashorts | |
01/11/2017 18:08 | Thanks - will be interesting not to follow the development of PeproStat. | bermudashorts |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions